<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>医麦客 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-16T11:13:48+08:00</updated>
  <subtitle>医麦客是一个聚焦转化医学、精准医疗和生物制药的专业媒体平台，持续关注体外诊断、抗体药物、细胞治疗、基因治疗等细分领域。为新生物医药医疗领域的企业发声，推动企业和行业的快速发展。</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>药融资丨深圳普瑞金生物药业有限公司完成1.4亿元B轮融资，并启动港股IPO</title>
    <updated>2020-11-15T23:31:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-15:/s/GiDi8Y9qgV8w_LL9GZb30w</id>
    <link href="https://mp.weixin.qq.com/s/GiDi8Y9qgV8w_LL9GZb30w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>西比曼生物更新CD19/CD20双特异性CAR-T临床进展，治疗复发难治性B-NHL数据亮眼丨医麦猛爆料</title>
    <updated>2020-11-15T23:31:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-15:/s/n0Sx3Viao01a4GzZlRj43A</id>
    <link href="https://mp.weixin.qq.com/s/n0Sx3Viao01a4GzZlRj43A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>从License-in到License-out，中国生物创新型药企走出国门 | 医麦新观察</title>
    <updated>2020-11-15T23:31:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-15:/s/AAl1rnsql48jEOY1Y5g-Og</id>
    <link href="https://mp.weixin.qq.com/s/AAl1rnsql48jEOY1Y5g-Og" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>暴露肿瘤细胞，隐藏健康细胞！CD33 CAR-T搭配新型造血干细胞对抗AML丨医麦猛爆料</title>
    <updated>2020-11-15T23:31:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-15:/s/ygYTvzRpqjJLsQaQjoYdCg</id>
    <link href="https://mp.weixin.qq.com/s/ygYTvzRpqjJLsQaQjoYdCg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>千面新原力：千名科学家及企业家共话生物医药未来</title>
    <updated>2020-11-15T23:31:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-15:/s/1W7GTI6wapW46RuR9-YZrA</id>
    <link href="https://mp.weixin.qq.com/s/1W7GTI6wapW46RuR9-YZrA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>ASH 2020：NK细胞治疗在血液疾病的新进展丨医麦新观察</title>
    <updated>2020-11-15T11:51:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-15:/s/zynyh2OE_tzeK1vDuzI1VA</id>
    <link href="https://mp.weixin.qq.com/s/zynyh2OE_tzeK1vDuzI1VA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Nature综述：PD-1/L1抑制剂的联合用药在其临床试验中已居C位丨医麦新观察</title>
    <updated>2020-11-15T11:51:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-15:/s/GtTE-H6K-12PJU0lcBhT4g</id>
    <link href="https://mp.weixin.qq.com/s/GtTE-H6K-12PJU0lcBhT4g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>胰腺癌精准治疗新希望！新型ADC抗肿瘤效果最优 | 医麦猛爆料</title>
    <updated>2020-11-15T11:51:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-15:/s/d9iSQbek3CbOJzEAb7wjWg</id>
    <link href="https://mp.weixin.qq.com/s/d9iSQbek3CbOJzEAb7wjWg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>新型“现货”CAR-T在显示出对实体瘤的治疗潜力，同种异体策略是未来的发展趋势丨医麦猛爆料</title>
    <updated>2020-11-14T11:08:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-14:/s/1NySyQvCgL0dzQsmibhBFg</id>
    <link href="https://mp.weixin.qq.com/s/1NySyQvCgL0dzQsmibhBFg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>三叶草生物与澳斯康生物制药签署战略合作协议，加速“S-三聚体”亚单位新冠疫苗产业化</title>
    <updated>2020-11-14T11:08:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-14:/s/4_B0XIEXL5OI5zdRzCJvrg</id>
    <link href="https://mp.weixin.qq.com/s/4_B0XIEXL5OI5zdRzCJvrg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>复星医药和 BioNTech宣布其mRNA候选疫苗BNT162b2 获中国国家药监局临床试验批准</title>
    <updated>2020-11-14T11:08:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-14:/s/tc6-iGQ1N-IzJ45ByK1kJA</id>
    <link href="https://mp.weixin.qq.com/s/tc6-iGQ1N-IzJ45ByK1kJA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>浙大首次报道iPSC来源的CAR-巨噬细胞(CAR-iMac)可用于新型免疫细胞治疗丨医麦猛爆料</title>
    <updated>2020-11-14T11:08:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-14:/s/udJHGNGjn1w8g9kl0mkJuw</id>
    <link href="https://mp.weixin.qq.com/s/udJHGNGjn1w8g9kl0mkJuw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>世界防治糖尿病日丨糖尿病治疗新策略知道多少</title>
    <updated>2020-11-14T11:08:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-14:/s/QxajcQ1Z9eoqfq1dig1l2Q</id>
    <link href="https://mp.weixin.qq.com/s/QxajcQ1Z9eoqfq1dig1l2Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>TCR²与ElevateBio建立合作伙伴关系以扩大生产能力，CDMO企业为生产赋能丨医麦猛爆料</title>
    <updated>2020-11-14T11:08:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-14:/s/hI4DezMEA4rqIiEaDb8iyg</id>
    <link href="https://mp.weixin.qq.com/s/hI4DezMEA4rqIiEaDb8iyg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>「峰客访谈」珠海生码医学董事长杨海涛：mRNA疫苗研发备受瞩目，防治多种疾病未来可期</title>
    <updated>2020-11-14T11:08:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-14:/s/5PuRQVkSDYX-6mBF-_Allg</id>
    <link href="https://mp.weixin.qq.com/s/5PuRQVkSDYX-6mBF-_Allg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>新华网专访赛傲生物张传宇：干细胞产业化助力健康中国</title>
    <updated>2020-11-12T22:49:06+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-12:/s/awfyWoML5klkKfOtMaZ9-w</id>
    <link href="https://mp.weixin.qq.com/s/awfyWoML5klkKfOtMaZ9-w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>疾病控制率达90%！mRNA肿瘤疫苗联合PD-1显示出强大的抗肿瘤活性丨医麦猛爆料</title>
    <updated>2020-11-12T22:49:06+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-12:/s/Bo5X37hHDL09i_6txceyEg</id>
    <link href="https://mp.weixin.qq.com/s/Bo5X37hHDL09i_6txceyEg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>俄罗斯上市新冠疫苗有效率达到92%，西藏诺迪康药业以900万美元买下该疫苗在中国的权益丨医麦猛爆料</title>
    <updated>2020-11-12T22:49:06+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-12:/s/kfiFpKunxBj3On-Bpk5kPQ</id>
    <link href="https://mp.weixin.qq.com/s/kfiFpKunxBj3On-Bpk5kPQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>「峰客访谈」​上海药物研究所戚新明博士：罕见病患者人群巨大，基因治疗大有可为</title>
    <updated>2020-11-12T22:49:06+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-12:/s/rrxn3xa1Di4lZrz1XSXrnQ</id>
    <link href="https://mp.weixin.qq.com/s/rrxn3xa1Di4lZrz1XSXrnQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>市场还在继续膨胀，一览年龄相关性黄斑变性治疗策略丨医麦黑科技</title>
    <updated>2020-11-12T08:30:43+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-12:/s/ArkRBm6aobKlNK98agALjA</id>
    <link href="https://mp.weixin.qq.com/s/ArkRBm6aobKlNK98agALjA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>